Zonisamide-induced weight loss in schizophrenia: Case series

Jaewon Yang; Moon Soo Lee; Sook Haeng Joe; In Kwa Jung; Seung Hyun Kim

doi:10.1097/WNF.0b013e3181c848a0

Zonisamide-induced weight loss in schizophrenia: Case series

Jaewon Yang, Moon Soo Lee, Sook Haeng Joe, In Kwa Jung, Seung Hyun Kim

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

Weight gain and metabolic disturbances constitute bothersome problems in schizophrenic patients treated with atypical antipsychotics. Several medications, exercise regimens, and lifestyle changes have been used in attempts to ameliorate these problems. We describe 3 patients with schizophrenia who manifested distinct weight loss and reduction in waist circumference during medication with zonisamide. This report suggests that zonisamide might be associated with weight loss in patients with schizophrenia.

Original language	English
Pages (from-to)	104-106
Number of pages	3
Journal	Clinical Neuropharmacology
Volume	33
Issue number	2
DOIs	https://doi.org/10.1097/WNF.0b013e3181c848a0
Publication status	Published - 2010 Mar
Externally published	Yes

Keywords

Obesity
Schizophrenia
Waist circumference
Weight loss
Zonisamide

ASJC Scopus subject areas

Pharmacology
Clinical Neurology
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/WNF.0b013e3181c848a0

Cite this

@article{8626868fd12b40429c2a50b6d67e82a5,

title = "Zonisamide-induced weight loss in schizophrenia: Case series",

abstract = "Weight gain and metabolic disturbances constitute bothersome problems in schizophrenic patients treated with atypical antipsychotics. Several medications, exercise regimens, and lifestyle changes have been used in attempts to ameliorate these problems. We describe 3 patients with schizophrenia who manifested distinct weight loss and reduction in waist circumference during medication with zonisamide. This report suggests that zonisamide might be associated with weight loss in patients with schizophrenia.",

keywords = "Obesity, Schizophrenia, Waist circumference, Weight loss, Zonisamide",

author = "Jaewon Yang and Lee, {Moon Soo} and Joe, {Sook Haeng} and Jung, {In Kwa} and Kim, {Seung Hyun}",

year = "2010",

month = mar,

doi = "10.1097/WNF.0b013e3181c848a0",

language = "English",

volume = "33",

pages = "104--106",

journal = "Clinical Neuropharmacology",

issn = "0362-5664",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Zonisamide-induced weight loss in schizophrenia

T2 - Case series

AU - Yang, Jaewon

AU - Lee, Moon Soo

AU - Joe, Sook Haeng

AU - Jung, In Kwa

AU - Kim, Seung Hyun

PY - 2010/3

Y1 - 2010/3

N2 - Weight gain and metabolic disturbances constitute bothersome problems in schizophrenic patients treated with atypical antipsychotics. Several medications, exercise regimens, and lifestyle changes have been used in attempts to ameliorate these problems. We describe 3 patients with schizophrenia who manifested distinct weight loss and reduction in waist circumference during medication with zonisamide. This report suggests that zonisamide might be associated with weight loss in patients with schizophrenia.

AB - Weight gain and metabolic disturbances constitute bothersome problems in schizophrenic patients treated with atypical antipsychotics. Several medications, exercise regimens, and lifestyle changes have been used in attempts to ameliorate these problems. We describe 3 patients with schizophrenia who manifested distinct weight loss and reduction in waist circumference during medication with zonisamide. This report suggests that zonisamide might be associated with weight loss in patients with schizophrenia.

KW - Obesity

KW - Schizophrenia

KW - Waist circumference

KW - Weight loss

KW - Zonisamide

UR - http://www.scopus.com/inward/record.url?scp=77951071549&partnerID=8YFLogxK

U2 - 10.1097/WNF.0b013e3181c848a0

DO - 10.1097/WNF.0b013e3181c848a0

M3 - Article

C2 - 19935403

AN - SCOPUS:77951071549

SN - 0362-5664

VL - 33

SP - 104

EP - 106

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

IS - 2

ER -

Zonisamide-induced weight loss in schizophrenia: Case series

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this